Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours

NCT02020577 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Cetuximab( erbitux®)
DRUG: Afatinib

Sponsor

Boehringer Ingelheim